N-acetylcysteine has been shown in a randomized controlled trial to improve transplant-free survival in non–acetaminophen-related acute liver failure in patients with grade I or II hepatic encephalopathy
If you want to change selection, open document below and click on "Move attachment"
- (no access) - MKSAP_17.pdf, p2727
|status||not read|| ||reprioritisations|
|last reprioritisation on|| ||suggested re-reading day|
|started reading on|| ||finished reading on|